Associations of the magnesium depletion score and magnesium intake with diabetes among US adults: an analysis of the National Health and Nutrition Examination Survey 2011-2018
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
OBJECTIVES: The magnesium depletion score (MDS) is considered more reliable than traditional approaches for predicting magnesium deficiency in humans. We explored the associations of MDS and dietary magnesium intake with diabetes. METHODS: We obtained data from 18,853 participants in the National Health and Nutrition Examination Survey 2011-2018. Using multivariate regression and stratified analysis, we investigated the relationships of both MDS and magnesium intake with diabetes. To compute prevalence ratios (PRs), we employed modified Poisson or log-binomial regression. We characterized the non-linear association between magnesium intake and diabetes using restricted cubic spline analysis. RESULTS: Participants with MDS ≥ 2 exhibited a PR of 1.26 (95% confidence interval [CI], 1.19 to 1.34) for diabetes. Per-standard deviation (SD) increase in dietary magnesium intake was associated with a lower prevalence of diabetes (PR, 0.91; 95% CI, 0.87 to 0.96). Subgroup analyses revealed a positive association between MDS ≥ 2 and diabetes across all levels of dietary magnesium intake, including the lowest (PR, 1.35; 95% CI, 1.18 to 1.55), middle (PR, 1.23; 95% CI, 1.12 to 1.35), and highest tertiles (PR, 1.25; 95% CI, 1.13 to 1.37; pinteraction< 0.001). Per-SD increase in magnesium intake was associated with lower diabetes prevalence in participants with MDS < 2 (PR, 0.92; 95% CI, 0.87 to 0.98) and those with MDS ≥ 2 (PR, 0.91; 95% CI, 0.84 to 0.98; pinteraction= 0.030). CONCLUSIONS: MDS is associated with diabetes, particularly among individuals with low magnesium intake. Adequate dietary magnesium intake may reduce diabetes risk, especially in those with high MDS.
Abstract
OBJECTIVES: The magnesium depletion score (MDS) is considered more reliable than traditional approaches for predicting magnesium deficiency in humans. We explored the associations of MDS and dietary magnesium intake with diabetes. METHODS: We obtained data from 18,853 participants in the National Health and Nutrition Examination Survey 2011-2018. Using multivariate regression and stratified analysis, we investigated the relationships of both MDS and magnesium intake with diabetes. To compute prevalence ratios (PRs), we employed modified Poisson or log-binomial regression. We characterized the non-linear association between magnesium intake and diabetes using restricted cubic spline analysis. RESULTS: Participants with MDS ≥ 2 exhibited a PR of 1.26 (95% confidence interval [CI], 1.19 to 1.34) for diabetes. Per-standard deviation (SD) increase in dietary magnesium intake was associated with a lower prevalence of diabetes (PR, 0.91; 95% CI, 0.87 to 0.96). Subgroup analyses revealed a positive association between MDS ≥ 2 and diabetes across all levels of dietary magnesium intake, including the lowest (PR, 1.35; 95% CI, 1.18 to 1.55), middle (PR, 1.23; 95% CI, 1.12 to 1.35), and highest tertiles (PR, 1.25; 95% CI, 1.13 to 1.37; pinteraction< 0.001). Per-SD increase in magnesium intake was associated with lower diabetes prevalence in participants with MDS < 2 (PR, 0.92; 95% CI, 0.87 to 0.98) and those with MDS ≥ 2 (PR, 0.91; 95% CI, 0.84 to 0.98; pinteraction= 0.030). CONCLUSIONS: MDS is associated with diabetes, particularly among individuals with low magnesium intake. Adequate dietary magnesium intake may reduce diabetes risk, especially in those with high MDS.
참고문헌 (39)
- Narayan KV, "Type 2 diabetes: why we are winning the battle but losing the war? 2015 Kelly West Award Lecture", Diabetes Care, 39, pp.653~663 (2016)[DOI]
- Schulze MB, "Primary prevention of diabetes : what can be done and how much can be prevented?", Annu Rev Public Health, 26, pp.445~467 (2005)[DOI]
- Guess ND, "Dietary interventions for the prevention of type 2 diabetes in high-risk groups : current state of evidence and future research needs", Nutrients, 10, pp.1245~ (2018)
- Lynch EB, "Randomized trial of a lifestyle intervention for urban low-income African Americans with type 2 diabetes", J Gen Intern Med, 34, pp.1174~1183 (2019)[DOI]
- Veronese N, "Oral magnesium supplementation for treating glucose metabolism parameters in people with or at risk of diabetes : a systematic review and meta-analysis of double-blind randomized controlled trials", Nutrients, 13, pp.4074~ (2021)[DOI]
- Franken GA, "Structural and functional comparison of magnesium transporters throughout evolution", Cell Mol Life Sci, 79, pp.418~ (2022)[DOI]
- Pelczyńska M, "The role of magnesium in the pathogenesis of metabolic disorders", Nutrients, 14, pp.1714~ (2022)[DOI]
- de Sousa Melo SR, "Participation of magnesium in the secretion and signaling pathways of insulin : an updated review", Biol Trace Elem Res, 200, pp.3545~3553 (2022)[DOI]
- Gommers LM, "Hypomagnesemia in type 2 diabetes : a vicious circle?", Diabetes, 65, pp.3~13 (2016)[DOI]
- Tarleton EK, "Factors influencing magnesium consumption among adults in the United States", Nutr Rev, 76, pp.526~538 (2018)
- Ismail AA, "Magnesium : a mineral essential for health yet generally underestimated or even ignored", J Nutr Food Sci, 6, pp.1~8 (2016)[DOI]
- Barbagallo M, "Magnesium intake in the pathophysiology and treatment of the cardiometabolic syndrome : where are we in 2006?", J Cardiometab Syndr, 1, pp.356~357 (2006)[DOI]
- Geiger H, "Magnesium in disease", Clin Kidney J, 5(Suppl 1), pp.i25~i38 (2012)[DOI]
- Kieboom BC, "Serum magnesium and the risk of prediabetes : a population-based cohort study", Diabetologia, 60, pp.843~853 (2017)[DOI]
- Workinger JL, "Challenges in the diagnosis of magnesium status", Nutrients, 10, pp.1202~ (2018)[DOI]
- Sales CH, "Magnesium and diabetes mellitus : their relation", Clin Nutr, 25, pp.554~562 (2006)[DOI]
- Zhao D, "Association of magnesium depletion score with congestive heart failure : results from the NHANES 2007-2016", Biol Trace Elem Res, 202, pp.454~465 (2024)[DOI]
- Hansen BA, "Hypomagnesemia in critically ill patients", J Intensive Care, 6, pp.21~ (2018)[DOI]
- Fan L, "Magnesium depletion score(MDS)predicts risk of systemic inflammation and cardiovascular mortality among US adults", J Nutr, 151, pp.2226~2235 (2021)[DOI]
- "About the National Health and Nutrition Examination Survey"[URL]
- Levey AS, "K", DOQI clinical practice guidelines for chronic kidney disease : evaluation, classification, and stratification, 2002, pp.39(2 Suppl 1), S1~S266
- Levey AS, "A new equation to estimate glomerular filtration rate", Ann Intern Med, 150, pp.604~612 (2009)[DOI]
- "Measuring guides for the dietary recall interview"[URL]
- Willett W, "Total energy intake : implications for epidemiologic analyses", Am J Epidemiol, 124, pp.17~27 (1986)[DOI]
- McNutt LA, "Estimating the relative risk in cohort studies and clinical trials of common outcomes", Am J Epidemiol, 157, pp.940~943 (2003)[DOI]
- Zou G, "A modified poisson regression approach to prospective studies with binary data", Am J Epidemiol, 159, pp.702~706 (2004)[DOI]
- Harrell FE Jr, "Regression modeling strategies: with applications to linear models, logistic and ordinal regression, and survival analysis" (2017), Springer
- Zhao B, "Association of magnesium consumption with type 2 diabetes and glucose metabolism : a systematic review and pooled study with trial sequential analysis", Diabetes Metab Res Rev, 36, pp.e3243~ (2020)[DOI]
- Piuri G, "Magnesium in obesity, metabolic syndrome, and type 2 diabetes", Nutrients, 13, pp.320~ (2021)[DOI]
- DiNicolantonio JJ, "Subclinical magnesium deficiency : a principal driver of cardiovascular disease and a public health crisis", Open Heart, 5, pp.e000668~ (2018)[DOI]
- Ismail AA, "Chronic magnesium deficiency and human disease; time for reappraisal?", QJM, 111, pp.759~763 (2018)[DOI]
- Wang J, "Associations of the dietary magnesium intake and magnesium depletion score with osteoporosis among American adults : data from the National Health and Nutrition Examination Survey", Front Nutr, 9, pp.883264~ (2022)[DOI]
- Kostov K, "Effects of magnesium deficiency on mechanisms of insulin resistance in type 2 diabetes : focusing on the processes of insulin secretion and signaling", Int J Mol Sci, 20, pp.1351~ (2019)[DOI]
- Yaribeygi H, "Insulin resistance : review of the underlying molecular mechanisms", J Cell Physiol, 234, pp.8152~8161 (2019)[DOI]
- Phillips JA, "Dietary guidelines for Americans, 2020-2025", Workplace Health Saf, 69, pp.395~ (2021)[DOI]
- Zhang X, "The circulating concentration and 24-h urine excretion of magnesium dose-and time-dependently respond to oral magnesium supplementation in a meta-analysis of randomized controlled trials", J Nutr, 146, pp.595~602 (2016)[DOI]
- Xu T, "Nonlinear reduction in risk for type 2 diabetes by magnesium intake : an updated meta-analysis of prospective cohort studies", Biomed Environ Sci, 28, pp.527~534 (2015)[DOI]
- Fang X, "Dose-response relationship between dietary magnesium intake and risk of type 2 diabetes mellitus : a systematic review and meta-regression analysis of prospective cohort studies", Nutrients, 8, pp.739~ (2016)[DOI]
- Kappeler D, "Higher bioavailability of magnesium citrate as compared to magnesium oxide shown by evaluation of urinary excretion and serum levels after single-dose administration in a randomized cross-over study", BMC Nutr, 3, pp.7~ (2017)[DOI]
